Confirmed speakers include:
CHAIRMAN Benoit Dubuis, President, BioAlps; Director, Eclosion SA; former Head of Life Sciences, EPFL, Switzerland
Andrea Tasinato, Project Director, Development Economic Canton of Vaud, Switzerland
Raphaël Conz, Economic Promotion Manager, Office for Economic Affairs, Switzerland
Faraj F. Abdelnour , President, ACIDIM, France
Daniel Bertholet, Investment Director, Endeavour Vision, Switzerland
Hélène Chevrou-Séverac, Global Head, Health Economics & Market Access, Nestlé Health Sciences, Switzerland
Jans Keltjens, Chief Executive Officer, Endosense, Netherlands
Oern Stuge, Founder, ORSCO Lifesciences AG, Switzerland
Herb Riband, Vice President External Affairs International, Medtronic International, Switzerland
Elio Borgonovi, Senior Professor of Public Management, President of CeRGAS,Bocconi University, Italy
Crispin Simon, Formerly CEO, BioCompatibles, UK
Alex Bennett, Partner, CTPartners, UK
Conor Hanley,CEO, BiancaMed, Ireland
Fabrice Paublant, Former CEO, Laboratories Narval, France
Corinne Lebourgeois,Managing Director, MedC Partners, Switzerland
Josep LI. Sanfeliu, Partner, Ysios Capital Partners, Spain
Lukas Guenther, Partner, Wellington Partners, Germany
Diego Braguglia,General Partner, VI Partners, Switzerland
Antoine Papiernik,Managing Partner, Sofinnova Partners SA, France
Grant Bester, Chief Marketing Officer, Stryker Europe, Switzerland
Cliff Murphy, Business Development Manager EMEA,Molnlycke Health Care, UK
Markus Ott,VP EMEA Health Economics & Reimbursement, Covidien, Switzerland
Bulend Corbacioglu, Vice President, Business Development & Licensing, Covidien, USA
Janke J. Dittmer, Partner, Gilde Healthcare Partners, Netherlands
Previous attendees comments
"The recent session in London was terrific - well organized and efficient. It's clear that your meetings are playing an important role during a period when our industry is becoming even more global, and our capital markets are more cross-linked than ever before."
"We found the event very valuable and were very impressed with the calibre of the entrepreneurs and the good turn out from corporates and VCs too. A massive thank you from us"
"Both the number of investors and their calibre proved unrivalled in what was a thoroughly enjoyable and productive conference"
"Less is more and a critical mass of interesting investors"